Skip to main content

Ishara Investments LP

13F filer · CIK 0002111609
Reported Aug 14, 2026
Net buyer this quarter
13F portfolio value$136MU.S. long equity reported on 13F
Positions4116 new · 11 closed
Net flow last quarter+$21.2MBuys minus sells
Top 10 positions weight51.0%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 202641 positions
ACADAcadia Pharmaceuticals Inc$10.4M7.62%0.24%+233.3%Q4 2025
XERSXeris Biopharma Holdings, Inc.$9.74M7.16%0.71%+20.0%Q4 2025
BMRNBiomarin Pharmaceutical Inc$8.21M6.03%0.07%+75.0%Q4 2025
PRAXPraxis Precision Medicines, Inc.$7.55M5.55%0.08%Not reportedQ4 2025
RAREUltragenyx Pharmaceutical Inc.$6.84M5.03%0.21%+17.7%Q4 2025
AGIOAgios Pharmaceuticals, Inc.$6.09M4.47%0.28%Not reportedQ4 2025
INSMINSMED Inc$5.46M4.01%0.02%Not reportedQ4 2025
CRNXCrinetics Pharmaceuticals, Inc.$5.37M3.95%0.14%NewQ2 2026
ZNTLZentalis Pharmaceuticals, Inc.$4.97M3.65%1.43%-16.7%Q4 2025
PCVXVaxcyte, Inc.$4.77M3.50%0.06%+42.9%Q4 2025
ANNXAnnexon, Inc.$4.68M3.44%0.55%+370.6%Q4 2025
TVTXTravere Therapeutics, Inc.$4.66M3.42%0.09%-25.9%Q1 2026
TNXPTonix Pharmaceuticals Holding Corp.$4.32M3.17%2.01%NewQ2 2026
BBIOBridgeBio Pharma, Inc.$4.28M3.14%0.03%Not reportedQ4 2025
AXSMAxsome Therapeutics, Inc.$4.01M2.95%0.03%-60.0%Q1 2026
CTNMContineum Therapeutics, Inc.$3.36M2.47%0.89%+44.4%Q1 2026
LXRXLexicon Pharmaceuticals, Inc.$3.05M2.24%0.28%+40.9%Q4 2025
KURAKura Oncology, Inc.$3.04M2.23%0.31%NewQ2 2026
DBVTDBV Technologies S.A.$3.03M2.22%0.06%+80.0%Q1 2026
GMABGenmab A/S$2.82M2.07%Not reported+25.0%Q4 2025
CYTKCytokinetics Inc$2.79M2.05%0.03%NewQ2 2026
MLYSMineralys Therapeutics, Inc.$2.77M2.03%0.12%+25.0%Q1 2026
SLNSilence Therapeutics plc$2.43M1.79%0.04%-60.6%Q4 2025
NUVBNuvation Bio Inc.$2.1M1.54%0.11%Not reportedQ4 2025
WVEWave Life Sciences, Inc.$1.91M1.40%0.17%NewQ2 2026
NKTRNektar Therapeutics$1.86M1.37%0.13%Not reportedQ4 2025
SRRKScholar Rock Holding Corp$1.69M1.24%0.03%-46.4%Q1 2026
ELVNEnliven Therapeutics, Inc.$1.66M1.22%0.04%NewQ2 2026
ALNYAlnylam Pharmaceuticals, Inc.$1.54M1.13%0.00%Not reportedQ1 2026
BEAMBeam Therapeutics Inc.$1.41M1.03%0.04%-28.6%Q4 2025
SIONSionna Therapeutics, Inc.$1.35M0.99%0.27%+150.0%Q1 2026
ORICOric Pharmaceuticals, Inc.$1.33M0.98%0.12%+20.0%Q4 2025
NAMSNewAmsterdam Pharma Co N.V.$1.25M0.92%0.03%Not reportedQ4 2025
VRTXVertex Pharmaceuticals Inc / Ma$1.22M0.90%0.00%NewQ2 2026
SPRYARS Pharmaceuticals, Inc.$1.15M0.84%0.14%NewQ2 2026
MNPRMonopar Therapeutics$1.14M0.84%0.18%NewQ2 2026
ERASErasca, Inc.$751K0.55%0.01%NewQ2 2026
VERAVera Therapeutics, Inc.$440K0.32%0.01%-87.5%Q1 2026
IMTXImmatics N.V.$311K0.23%0.02%-80.0%Q4 2025
MREOMereo BioPharma Group plc$244K0.18%0.10%NewQ2 2026
GOSSGossamer Bio, Inc.$135K0.10%0.17%Not reportedQ1 2026
Q1 2026Reported May 15, 202636 positions
PRAXPraxis Precision Medicines, Inc.$7.27M6.88%0.08%-43.6%Q4 2025
AXSMAxsome Therapeutics, Inc.$6.93M6.56%0.08%NewQ1 2026
XERSXeris Biopharma Holdings, Inc.$5.95M5.63%0.59%+28.1%Q4 2025
KALVKalVista Pharmaceuticals, Inc.$5.57M5.27%0.54%NewQ1 2026
FOLDAmicus Therapeutics, Inc.$5.34M5.05%0.12%+2.5%Q4 2025
BMRNBiomarin Pharmaceutical Inc$4.63M4.39%0.04%-18.0%Q4 2025
VSTMVerastem, Inc.$4.35M4.11%0.93%+203.7%Q4 2025
RAREUltragenyx Pharmaceutical Inc.$3.65M3.46%0.18%+248.5%Q4 2025
ARWRArrowhead Pharmaceuticals, Inc.$3.47M3.29%0.04%NewQ1 2026
PCVXVaxcyte, Inc.$3.34M3.16%0.04%+14.8%Q4 2025
VERAVera Therapeutics, Inc.$3.3M3.12%0.13%NewQ1 2026
TVTXTravere Therapeutics, Inc.$3.29M3.11%0.12%NewQ1 2026
MLTXMoonLake Immunotherapeutics$3.25M3.08%0.33%NewQ1 2026
ZNTLZentalis Pharmaceuticals, Inc.$2.88M2.72%1.73%-6.8%Q4 2025
SRRKScholar Rock Holding Corp$2.82M2.67%0.05%NewQ1 2026
ACADAcadia Pharmaceuticals Inc$2.74M2.59%0.07%-23.1%Q4 2025
ARDXArdelyx, Inc.$2.7M2.56%0.18%NewQ1 2026
MLYSMineralys Therapeutics, Inc.$2.22M2.10%0.10%NewQ1 2026
GMABGenmab A/S$2.2M2.08%Not reported+17.1%Q4 2025
DBVTDBV Technologies S.A.$2.14M2.03%0.03%NewQ1 2026
CPRXCatalyst Pharmaceuticals, Inc.$2.03M1.92%0.07%NewQ1 2026
SIONSionna Therapeutics, Inc.$1.97M1.87%0.11%NewQ1 2026
CTNMContineum Therapeutics, Inc.$1.85M1.76%0.61%NewQ1 2026
ALNYAlnylam Pharmaceuticals, Inc.$1.7M1.61%0.00%NewQ1 2026
LGNDLigand Pharmaceuticals Inc$1.64M1.55%0.04%NewQ1 2026
EWTXEdgewise Therapeutics, Inc.$1.55M1.47%0.05%-15.2%Q4 2025
IMTXImmatics N.V.$1.51M1.43%0.11%+92.2%Q4 2025
LXRXLexicon Pharmaceuticals, Inc.$1.41M1.33%0.21%+2.5%Q4 2025
BEAMBeam Therapeutics Inc.$1.37M1.29%0.06%+14.8%Q4 2025
ORICOric Pharmaceuticals, Inc.$1.3M1.23%0.10%-35.9%Q4 2025
NAMSNewAmsterdam Pharma Co N.V.$1.18M1.12%0.03%+23.0%Q4 2025
ANNXAnnexon, Inc.$965K0.91%0.12%-76.8%Q4 2025
IDYAIDEAYA Biosciences, Inc.$820K0.78%0.03%NewQ1 2026
SLNSilence Therapeutics plc$740K0.70%0.10%-41.5%Q4 2025
PTCTPTC Therapeutics, Inc.$698K0.66%0.01%-71.5%Q4 2025
GOSSGossamer Bio, Inc.$269K0.26%0.35%NewQ1 2026
Q4 2025Reported Feb 17, 202637 positions
PRAXPraxis Precision Medicines, Inc.$11.8M13.48%0.16%NewQ4 2025
XERSXeris Biopharma Holdings, Inc.$6.28M7.18%0.48%NewQ4 2025
BMRNBiomarin Pharmaceutical Inc$5.94M6.80%0.05%NewQ4 2025
FOLDAmicus Therapeutics, Inc.$5.13M5.86%0.12%NewQ4 2025
ACADAcadia Pharmaceuticals Inc$4.27M4.89%0.09%NewQ4 2025
ANNXAnnexon, Inc.$3.77M4.31%0.50%NewQ4 2025
NUVBNuvation Bio Inc.$3.58M4.10%0.12%NewQ4 2025
BBIOBridgeBio Pharma, Inc.$2.75M3.15%0.02%NewQ4 2025
PTCTPTC Therapeutics, Inc.$2.73M3.13%0.04%NewQ4 2025
UTHRUNITED THERAPEUTICS Corp$2.68M3.06%0.01%NewQ4 2025
BCRXBiocryst Pharmaceuticals Inc$2.34M2.68%0.14%NewQ4 2025
PCVXVaxcyte, Inc.$2.31M2.64%0.04%NewQ4 2025
GMABGenmab A/S$2.16M2.47%Not reportedNewQ4 2025
SNDXSyndax Pharmaceuticals Inc$2.1M2.40%0.11%NewQ4 2025
VSTMVerastem, Inc.$2.08M2.38%0.35%NewQ4 2025
TARSTarsus Pharmaceuticals, Inc.$1.97M2.25%0.06%NewQ4 2025
APOGApogee Enterprises, Inc.$1.89M2.16%0.12%NewQ4 2025
ZNTLZentalis Pharmaceuticals, Inc.$1.78M2.04%1.91%NewQ4 2025
INSMINSMED Inc$1.74M1.99%0.00%NewQ4 2025
SLNSilence Therapeutics plc$1.46M1.67%0.17%NewQ4 2025
EWTXEdgewise Therapeutics, Inc.$1.44M1.65%0.05%NewQ4 2025
BEAMBeam Therapeutics Inc.$1.39M1.58%0.05%NewQ4 2025
ORICOric Pharmaceuticals, Inc.$1.31M1.50%0.16%NewQ4 2025
APLSApellis Pharmaceuticals, Inc.$1.26M1.44%0.04%NewQ4 2025
DNLIDenali Therapeutics Inc.$1.16M1.32%0.04%NewQ4 2025
RAREUltragenyx Pharmaceutical Inc.$1.15M1.31%0.05%NewQ4 2025
ASNDAscendis Pharma A/S$1.07M1.22%0.01%NewQ4 2025
NAMSNewAmsterdam Pharma Co N.V.$1.05M1.20%0.03%NewQ4 2025
LXRXLexicon Pharmaceuticals, Inc.$1.01M1.16%0.24%NewQ4 2025
BHVNBiohaven Ltd.$994K1.14%0.07%NewQ4 2025
DNTHDianthus Therapeutics, Inc.$989K1.13%0.06%NewQ4 2025
NKTRNektar Therapeutics$846K0.97%0.10%NewQ4 2025
IMTXImmatics N.V.$840K0.96%0.06%NewQ4 2025
AGIOAgios Pharmaceuticals, Inc.$817K0.93%0.05%NewQ4 2025
IMVTImmunovant, Inc.$763K0.87%0.01%NewQ4 2025
OLMAOlema Pharmaceuticals, Inc.$750K0.86%0.04%NewQ4 2025
ARQTArcutis Biotherapeutics, Inc.$348K0.40%0.01%NewQ4 2025
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.